Disc Medicine Lands Million: Investors React to FDA Catalyst
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Knowing what to include in your retirement portfolio at 30 can set you up for success. Learn about essential assets and strategies.
20,742 articlesA private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
As volatility remains a theme, smart investors are looking for growth stocks first half opportunities with real catal...
A mid-February 2026 SEC filing shows Bank Hapoalim taking a new position in the FTCS ETF, worth about $14.7 million. ...
Oracle is pursuing aggressive growth through heavy spending. This article breaks down the rationale, the risks, and w...
Investors are weighing how legal rulings against Meta could reshape risk and earnings. This guide breaks down what ha...
A mandatory ethics disclosure reveals the trump family trust bought crypto-related stocks in early 2026, including Co...
A new wave of government-backed AI infrastructure could unlock enormous opportunities for investors. This guide expla...
When a top Remitly executive sells shares, investors want to know what it means. This guide explains insider sales, h...
Berkshire Hathaway's Greg Abel could be quietly steering a strategic tilt toward AI-enabled winners. This deep dive e...
Yum! Brands is selling Pizza Hut in two moves, reshaping its portfolio. This could boost balance sheet strength and s...
A little-known aerospace stock has delivered a blistering 470% gain over five years and recently reached a fresh all-...
A little-known corner of the market, rare earth stocks have moved in big swings. Here's how USA Rare Earth powered an...